Mercator Medical S.A. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was PLN 286.08 million compared to PLN 1,087.3 million a year ago. Revenue was PLN 319.92 million compared to PLN 1,090.58 million a year ago.

Net loss was PLN 4.19 million compared to net income of PLN 402.08 million a year ago. Basic loss per share from continuing operations was PLN 0.43 compared to basic earnings per share from continuing operations of PLN 38.82 a year ago. Diluted loss per share from continuing operations was PLN 0.43 compared to diluted earnings per share from continuing operations of PLN 38.67 a year ago.